France· FR:69586252
RUBRACA 250 mg, comprimé pelliculé
A medicinal product containing camsylate de rucaparib, registered in France by PHARMAAND (AUTRICHE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CAMSYLATE DE RUCAPARIB
- Manufacturer
- PHARMAAND (AUTRICHE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301689291 flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s)EUR 2.24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Camsylate de rucaparib in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/099989f2-ee01-4531-98b0-d3e0aa55a7a9 GET /v1/drugs/099989f2-ee01-4531-98b0-d3e0aa55a7a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69586252",
"date_amm": "2018-05-24",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1250",
"substance": "CAMSYLATE DE RUCAPARIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about camsylate de rucaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.